# Effects of 6-Weeks High-Intensity Interval Training in Schoolchildren with Insulin Resistance: Influence of Biological Maturation on Metabolic, Body Composition, Cardiovascular and Performance Non-responses

PMID: 28706490
Journal: Frontiers in physiology
Published: 2017
Authors: Alvarez C, Ramírez-Campillo R, Ramírez-Vélez R, Izquierdo M

## Question

Do early and normal biological maturation groups differ in effects and non-responder prevalence for insulin resistance, body composition, cardiovascular, and performance outcomes after 6 weeks of school-based cycling HIIT?

## Summary

This randomized school-based intervention studied 29 sedentary insulin-resistant children classified as early or normal maturation after a 6-week cycling HIIT program. Both maturation groups improved fasting insulin, HOMA-IR, and skinfold measures, while non-responder prevalence for the metabolic outcomes did not differ between maturation groups. The protocol used 18 closely monitored cycling sessions with progressive interval duration and number.

## Population

- Sedentary insulin-resistant schoolchildren aged 8-13 years, grouped by early versus normal biological maturation.
- Sample size: 29
- Age: Overall 11.4 +/- 1.7 years; HIIT-EM 11.0 +/- 1.0 years and HIIT-NM 12.0 +/- 1.0 years.
- Sex: Reported inconsistently: Table 1 lists HIIT-EM 7 girls/4 boys and HIIT-NM 9 girls/8 boys, while Table 4 lists HIIT-EM 9 girls/3 boys and HIIT-NM 11 girls/6 boys.
- Fitness level: Physically inactive, no regular HIIT background; participated in normal physical education.
- Health status: Insulin resistance by HOMA-IR, fasting insulin, or fasting glucose; overweight/obesity range mean BMI.

## Methodology

- Randomized intervention comparing early-maturation and normal-maturation HIIT groups, with pre/post outcomes and responder/non-responder classification by typical error.
- 6 weeks of HIIT after familiarization and baseline assessment.
- School/community field setting in Chile with afternoon sessions monitored by exercise physiologists.
- Randomized study design.

## Protocol

- 6-week supervised cycling HIIT.
- Modality: Child-adapted cycle ergometer.
- Work intervals: 40 seconds weeks 1-2, 50 seconds weeks 3-5, 60 seconds week 6.
- Recovery: 120 seconds passive rest on the bicycle without movement.
- Sets or repetitions: 8 intervals weeks 1-2, 10 intervals weeks 3-4, 12 intervals weeks 5-6.
- Intensity: Modified Borg 1-10 RPE of 8-10; described as 70-100% maximum heart rate; cadence 50-70 rpm and speed 20-40 km/h.
- Session duration: 23.3 to 40.0 minutes depending on week.
- Frequency: 3 sessions per week.
- Program length: 6 weeks.
- Progression: Interval duration and interval count increased across weeks; ergometer load adjusted about every 2 weeks to maintain RPE 8-10.
- Same HIIT protocol in normal maturation group.
- Modality: Child-adapted cycle ergometer.
- Work intervals: Same as intervention.
- Recovery: Same as intervention.
- Sets or repetitions: Same as intervention.
- Intensity: Same RPE and estimated heart-rate target.
- Session duration: Same as intervention.
- Frequency: 3 sessions per week.
- Program length: 6 weeks.
- Progression: Same as intervention; comparison was maturation status rather than protocol dose.

## Outcomes

### Metabolic response non-responder prevalence
Status: no clear change
There were no significant differences between early and normal maturation groups in non-responder prevalence for fasting glucose, fasting insulin, or HOMA-IR.

FGL NRs 83.3% vs 94.1%, p=0.348; FINS NRs 33.3% vs 41.2%, p=0.668; HOMA-IR NRs 25.0% vs 35.3%, p=0.555.

### Fasting insulin and HOMA-IR
Status: improved
Both groups significantly decreased fasting insulin and HOMA-IR after 6 weeks.

FINS decreased 22.8% in HIIT-EM and 22.7% in HIIT-NM; HOMA-IR decreased 22.9% in HIIT-EM and 15.8% in HIIT-NM, reported p<0.05.

### Fasting glucose
Status: no clear change
Fasting glucose did not significantly change in either maturation group.

Reported as no significant changes.

### Skinfold measures
Status: improved
Both groups significantly decreased tricipital, suprailiac, and abdominal skinfolds; no non-responders were observed for tricipital or abdominal skinfold.

TSF -10.3% vs -6.8%; SSF -16.0% vs -18.9%; AbdSF -22.8% vs -15.9%; reported p<0.05 for significant decreases.

### Systolic blood pressure
Status: mixed
HIIT-EM significantly decreased systolic blood pressure, while HIIT-NM did not; non-responder prevalence differed between groups.

SBP -11.9% in HIIT-EM versus -2.8% in HIIT-NM; SBP NRs 41.6% vs 70.5%.

### Strength
Status: mixed
HIIT-NM significantly improved 1RM leg extension and upper row; HIIT-EM changes were not significant.

HIIT-NM 1RMLE +42.1% and 1RMUR +25.0%, both p<0.001.

### Safety and tolerability
Status: no clear change
All subjects had good exercise tolerance and no participant reported an injury.

## Practical Insights

- A short 6-week progressive cycling HIIT program can improve insulin-resistance markers and skinfolds in supervised sedentary children with insulin resistance.
- Individual response should be expected; mean improvement in insulin and HOMA-IR coexisted with substantial non-responder prevalence for fasting glucose and some other variables.
- For youth or clinical-risk programming, supervision, familiarization, and attendance monitoring are key context, not optional details.

## Limitations

- No non-exercise control group.
- Small analyzed sample.
- Special pediatric insulin-resistant population.
- Additional exercise after training sessions was not controlled.
- Attendance-based exclusion may limit generalizability.
- Sex distribution differs between reported tables.

## Safety And Adherence

- All subjects had good exercise tolerance.
- None of the participants reported an injury.
- Sessions were closely monitored by exercise physiologists.

## Original Sources

- [PubMed](https://pubmed.ncbi.nlm.nih.gov/28706490/) (pubmed)
- [DOI](https://doi.org/10.3389/fphys.2017.00444) (doi)
- [PMC full text](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489677/) (full text)

## Agent Guidance

Preserve the paper-level scope of this note. Do not generalize beyond the population, protocol, measured outcomes, and limitations above.